TY - JOUR AU - Bao, S. AU - Wu, Q. AU - McLendon, R. E. PY - 2006 DA - 2006// TI - Glioma stem cells promote radioresistance by preferential activation of the DNA damage response JO - Nature VL - 444 UR - https://doi.org/10.1038/nature05236 DO - 10.1038/nature05236 ID - Bao2006 ER - TY - JOUR AU - Kim, N. AU - Chang, J. S. AU - Wee, C. W. PY - 2019 DA - 2019// TI - Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma JO - Strahlenther Onkol VL - 196 UR - https://doi.org/10.1007/s00066-019-01512-y DO - 10.1007/s00066-019-01512-y ID - Kim2019 ER - TY - JOUR AU - Choi, M. AU - Kipps, T. AU - Kurzrock, R. PY - 2016 DA - 2016// TI - ATM mutations in Cancer: therapeutic implications JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-15-0945 DO - 10.1158/1535-7163.MCT-15-0945 ID - Choi2016 ER - TY - JOUR AU - Lee, J. M. AU - Ledermann, J. A. AU - Kohn, E. C. PY - 2014 DA - 2014// TI - PARP inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt384 DO - 10.1093/annonc/mdt384 ID - Lee2014 ER - TY - JOUR AU - Hickson, I. AU - Zhao, Y. AU - Richardson, C. J. PY - 2004 DA - 2004// TI - Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-2727 DO - 10.1158/0008-5472.CAN-04-2727 ID - Hickson2004 ER - TY - JOUR AU - Rainey, M. D. AU - Charlton, M. E. AU - Stanton, R. V. PY - 2008 DA - 2008// TI - Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0763 DO - 10.1158/0008-5472.CAN-08-0763 ID - Rainey2008 ER - TY - JOUR AU - Roy, K. AU - Wang, L. AU - Makrigiorgos, G. M. PY - 2006 DA - 2006// TI - Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity JO - Biochem Biophys Res Commun VL - 344 UR - https://doi.org/10.1016/j.bbrc.2006.03.222 DO - 10.1016/j.bbrc.2006.03.222 ID - Roy2006 ER - TY - JOUR AU - Golding, S. E. AU - Rosenberg, E. AU - Adams, B. R. PY - 2012 DA - 2012// TI - Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control JO - Cell Cycle VL - 11 UR - https://doi.org/10.4161/cc.11.6.19576 DO - 10.4161/cc.11.6.19576 ID - Golding2012 ER - TY - JOUR AU - Biddlestone-Thorpe, L. AU - Sajjad, M. AU - Rosenberg, E. PY - 2013 DA - 2013// TI - ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-3408 DO - 10.1158/1078-0432.CCR-12-3408 ID - Biddlestone-Thorpe2013 ER - TY - JOUR AU - Durant, S. T. AU - Zheng, L. AU - Wang, Y. PY - 2018 DA - 2018// TI - The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models JO - Sci Adv VL - 4 UR - https://doi.org/10.1126/sciadv.aat1719 DO - 10.1126/sciadv.aat1719 ID - Durant2018 ER - TY - JOUR AU - Meyerson, M. AU - Gabriel, S. AU - Getz, G. PY - 2010 DA - 2010// TI - Advances in understanding cancer genomes through second-generation sequencing JO - Nat Rev Genet VL - 11 UR - https://doi.org/10.1038/nrg2841 DO - 10.1038/nrg2841 ID - Meyerson2010 ER - TY - JOUR AU - Lim, D. A. AU - Cha, S. AU - Mayo, M. C. PY - 2007 DA - 2007// TI - Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype JO - Neuro-Oncology VL - 9 UR - https://doi.org/10.1215/15228517-2007-023 DO - 10.1215/15228517-2007-023 ID - Lim2007 ER - TY - JOUR AU - Roh, T. H. AU - Park, H. H. AU - Kang, S. G. PY - 2017 DA - 2017// TI - Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: a single-center analysis JO - Medicine (Baltimore) VL - 96 UR - https://doi.org/10.1097/MD.0000000000007422 DO - 10.1097/MD.0000000000007422 ID - Roh2017 ER - TY - JOUR AU - Choi, S. H. AU - Kim, J. W. AU - Chang, J. S. PY - 2017 DA - 2017// TI - Impact of including Peritumoral edema in radiotherapy target volume on patterns of failure in Glioblastoma following Temozolomide-based Chemoradiotherapy JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep42148 DO - 10.1038/srep42148 ID - Choi2017 ER - TY - JOUR AU - Im, J. H. AU - Hong, J. B. AU - Kim, S. H. PY - 2018 DA - 2018// TI - Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-017-19014-1 DO - 10.1038/s41598-017-19014-1 ID - Im2018 ER - TY - JOUR AU - Na, K. AU - Kim, H. S. AU - Shim, H. S. PY - 2019 DA - 2019// TI - Targeted next-generation sequencing panel (TruSight tumor 170) in diffuse glioma: a single institutional experience of 135 cases JO - J Neuro-Oncol VL - 142 UR - https://doi.org/10.1007/s11060-019-03114-1 DO - 10.1007/s11060-019-03114-1 ID - Na2019 ER - TY - JOUR AU - Weber, A. M. AU - Ryan, A. J. PY - 2015 DA - 2015// TI - ATM and ATR as therapeutic targets in cancer JO - Pharmacol Ther VL - 149 UR - https://doi.org/10.1016/j.pharmthera.2014.12.001 DO - 10.1016/j.pharmthera.2014.12.001 ID - Weber2015 ER - TY - JOUR AU - Kim, Y. S. AU - Kim, S. H. AU - Cho, J. PY - 2012 DA - 2012// TI - MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study JO - Int J Radiat Oncol Biol Phys VL - 84 UR - https://doi.org/10.1016/j.ijrobp.2011.12.086 DO - 10.1016/j.ijrobp.2011.12.086 ID - Kim2012 ER - TY - JOUR AU - Brat, D. J. AU - Aldape, K. AU - Colman, H. PY - 2018 DA - 2018// TI - cIMPACT-NOW update 3: recommended diagnostic criteria for “diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” JO - Acta Neuropathol VL - 136 UR - https://doi.org/10.1007/s00401-018-1913-0 DO - 10.1007/s00401-018-1913-0 ID - Brat2018 ER - TY - STD TI - Chukwueke UN, Wen PY. Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice. CNS Oncol. 2019;8(1):CNS28-CNS. ID - ref20 ER - TY - JOUR AU - Taylor, A. M. AU - Harnden, D. G. AU - Arlett, C. F. PY - 1975 DA - 1975// TI - Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity JO - Nature VL - 258 UR - https://doi.org/10.1038/258427a0 DO - 10.1038/258427a0 ID - Taylor1975 ER - TY - JOUR AU - Chen, P. C. AU - Lavin, M. F. AU - Kidson, C. PY - 1978 DA - 1978// TI - Identification of ataxia telangiectasia heterozygotes, a cancer prone population JO - Nature VL - 274 UR - https://doi.org/10.1038/274484a0 DO - 10.1038/274484a0 ID - Chen1978 ER - TY - JOUR AU - Ma, J. AU - Setton, J. AU - Morris, L. PY - 2017 DA - 2017// TI - Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.14400 DO - 10.18632/oncotarget.14400 ID - Ma2017 ER - TY - JOUR AU - Su, Y. AU - Swift, M. PY - 2001 DA - 2001// TI - Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations JO - JAMA VL - 286 UR - https://doi.org/10.1001/jama.286.18.2233 DO - 10.1001/jama.286.18.2233 ID - Su2001 ER - TY - JOUR AU - Lee, J. J. B. AU - Yang, A. J. AU - Chang, J. S. PY - 2019 DA - 2019// TI - Genomic analysis reveals somatic mutations of ATM gene in DNA repair confer exceptional target lesion response to radiation therapy JO - J Glob Oncol VL - 5 UR - https://doi.org/10.1200/JGO.2019.5.suppl.130 DO - 10.1200/JGO.2019.5.suppl.130 ID - Lee2019 ER - TY - JOUR AU - Shiloh, Y. AU - Ziv, Y. PY - 2013 DA - 2013// TI - The ATM protein kinase: regulating the cellular response to genotoxic stress, and more JO - Nat Rev Mol Cell Biol VL - 14 UR - https://doi.org/10.1038/nrm3546 DO - 10.1038/nrm3546 ID - Shiloh2013 ER - TY - JOUR AU - Bakkenist, C. J. AU - Kastan, M. B. PY - 2003 DA - 2003// TI - DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation JO - Nature VL - 421 UR - https://doi.org/10.1038/nature01368 DO - 10.1038/nature01368 ID - Bakkenist2003 ER - TY - JOUR AU - Matsuoka, S. AU - Huang, M. AU - Elledge, S. J. PY - 1998 DA - 1998// TI - Linkage of ATM to cell cycle regulation by the Chk2 protein kinase JO - Science VL - 282 UR - https://doi.org/10.1126/science.282.5395.1893 DO - 10.1126/science.282.5395.1893 ID - Matsuoka1998 ER - TY - JOUR AU - Durant, S. T. AU - Nickoloff, J. A. PY - 2005 DA - 2005// TI - Good timing in the cell cycle for precise DNA repair by BRCA1 JO - Cell Cycle VL - 4 UR - https://doi.org/10.4161/cc.4.9.2027 DO - 10.4161/cc.4.9.2027 ID - Durant2005 ER - TY - JOUR AU - Durant, S. T. AU - Paffett, K. S. AU - Shrivastav, M. PY - 2006 DA - 2006// TI - UV radiation induces delayed hyperrecombination associated with hypermutation in human cells JO - Mol Cell Biol VL - 26 UR - https://doi.org/10.1128/MCB.00444-06 DO - 10.1128/MCB.00444-06 ID - Durant2006 ER - TY - JOUR AU - Blasius, M. AU - Bartek, J. PY - 2013 DA - 2013// TI - ATM targets hnRNPK to control p53 JO - Cell Cycle VL - 12 UR - https://doi.org/10.4161/cc.24485 DO - 10.4161/cc.24485 ID - Blasius2013 ER - TY - STD TI - Berthel E, Foray N, Ferlazzo ML. The Nucleoshuttling of the ATM Protein: A Unified Model to Describe the Individual Response to High- and Low-Dose of Radiation? Cancers (Basel). 2019;11(7). ID - ref32 ER - TY - JOUR AU - Scott, J. G. AU - Berglund, A. AU - Schell, M. J. PY - 2017 DA - 2017// TI - A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study JO - Lancet Oncol VL - 18 UR - https://doi.org/10.1016/S1470-2045(16)30648-9 DO - 10.1016/S1470-2045(16)30648-9 ID - Scott2017 ER - TY - JOUR AU - Hahnen, E. AU - Lederer, B. AU - Hauke, J. PY - 2017 DA - 2017// TI - Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast Cancer: secondary analysis of the GeparSixto randomized clinical trial JO - JAMA Oncol VL - 3 UR - https://doi.org/10.1001/jamaoncol.2017.1007 DO - 10.1001/jamaoncol.2017.1007 ID - Hahnen2017 ER - TY - JOUR AU - Copson, E. R. AU - Maishman, T. C. AU - Tapper, W. J. PY - 2018 DA - 2018// TI - Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study JO - Lancet Oncol. VL - 19 UR - https://doi.org/10.1016/S1470-2045(17)30891-4 DO - 10.1016/S1470-2045(17)30891-4 ID - Copson2018 ER - TY - JOUR AU - McLaughlin, J. R. AU - Rosen, B. AU - Moody, J. PY - 2013 DA - 2013// TI - Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2 JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djs494 DO - 10.1093/jnci/djs494 ID - McLaughlin2013 ER -